Figure 4
Kaplan-Meier survival estimates according to the cytogenetic status. (A) Data are shown for OS for CK+/MK− AML and CK+/MK+ AML. (B) Data are shown for OS for the subgroups CK+/MK−/TP53unaltered, CK+/MK−/TP53altered, CK+/MK+/TP53unaltered, and CK+/MK+/TP53altered.

Kaplan-Meier survival estimates according to the cytogenetic status. (A) Data are shown for OS for CK+/MK− AML and CK+/MK+ AML. (B) Data are shown for OS for the subgroups CK+/MK−/TP53unaltered, CK+/MK−/TP53altered, CK+/MK+/TP53unaltered, and CK+/MK+/TP53altered.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal